Glyphic Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Glyphic Biotechnologies's estimated annual revenue is currently $2M per year.
- Glyphic Biotechnologies's estimated revenue per employee is $80,600
- Glyphic Biotechnologies's total funding is $6.1M.
Employee Data
- Glyphic Biotechnologies has 25 Employees.
- Glyphic Biotechnologies grew their employee count by 19% last year.
Glyphic Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 150% | N/A | N/A |
#5 | $1.4M | 9 | 0% | N/A | N/A |
#6 | N/A | 7 | 40% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.5M | 12 | 9% | N/A | N/A |
What Is Glyphic Biotechnologies?
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
keywords:N/A
$6.1M
Total Funding
25
Number of Employees
$2M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Glyphic Biotechnologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CTO and Co-Founder | |
2 | Associate Scientist I | |
3 | Senior Patent Agent | |
4 | Antibody Engineering Scientist II | |
5 | Scientist I | |
6 | Lab Operations Manager | |
7 | Senior Scientist | |
8 | Scientist | |
9 | Co-Founder and CEO | |
10 | Research Associate, Chemistry I |
Other Companies in San Francisco Bay Area
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.6M | 26 | 13% | N/A |
#2 | $7.1M | 33 | 6% | N/A |
#3 | $7.1M | 33 | 38% | N/A |
#4 | $7M | 35 | 13% | N/A |
#5 | $12.6M | 52 | 8% | N/A |